Notable Analyst Rating Changes 03/19: (JNPR) (TEVA) (EPD) Upgraded; (OWW) (HSBC) (IO) Downgraded Mar 19, 2014 10:56AM
Barclays Upgrades Teva Pharma (TEVA) to Overweight Mar 7, 2014 06:53AM
Notable Analyst Rating Changes 11/04: (X) (GTI) (KSS) Upgraded; (BPI) (GPS) (AFL) Downgraded Nov 4, 2013 10:44AM
Pre-Open Stock Movers 8/5: (CGEN) (VRNG) (TSN) Higher; (FOSL) (CBOE) (QCOM) Lower (more...) Aug 5, 2013 09:40AM
Streetinsider.com Pre-Open Movers 07/30: (STXS) (VNDA) (AEGR) Higher; (MOS) (POT) (COH) Lower (more...) Jul 30, 2013 09:37AM


Dec 12, 2012 03:28PM Stocks Crossing 50-Day SMA 12/12: (TSL) (XOM) JOY) Above; (TEVA) (KOG) (TLT) Below
Jun 19, 2012 03:48PM Barclays on U.S. Specialty Pharmaceuticals: Muddling Now, but Opportunity Remains
May 25, 2012 01:21PM Barclays Maintains an 'Equalweight' on Teva Pharma (TEVA); Adjusting Estimates After Business Update
May 11, 2012 01:26PM Barclays on Healthcare: Top Takeaways from our Second Annual Therapeutics Symposium
Apr 9, 2012 02:10PM Barclays on U.S. Specialty Pharmaceuticals: Model Adjustments on MYL, PRX, TEVA, & WCRX
Mar 15, 2012 10:43AM Notable Analyst Rating Changes 03/15: (AMD) (UNP) (LVLT) Upgraded; (EBAY) (LAZ) (WMS) Downgraded
Feb 15, 2012 02:08PM Unusual 11 Midday Movers 02/15: (BPAX) (EGY) (THLD) Higher; (ZNGA) (PWAV) (IPSU) Lower
Feb 15, 2012 11:23AM Morning Movers 02/15: (BPAX) (EGY) (IPAS) (CBK) Higher; (VG) (ZNGA) (ACPW) Lower
Dec 9, 2011 01:15PM Barclays Initiating Coverage: A Seamless Approach to Biopharmaceuticals
Nov 8, 2011 11:05AM Notable Analyst Rating Changes 11/08: (MFA) (EMR) (STJ) Upgraded; (ALU) (RIMM) (PXD) Downgraded
Nov 3, 2011 11:15AM Notable Analyst Rating Changes 11/03: (TEVA) (ARO) (OPEN) Upgraded; (DNDN) (DXCM) (NLY) Downgraded
Oct 24, 2011 10:47AM Notable Analyst Rating Changes 10/24: (BHP) (XL) (USU) Upgraded; (WEN) (IFF) (TEVA) Downgraded
May 16, 2011 02:05PM Global Pharmaceuticals: Global Therapeutic Conference 2011: Focus on Real-World Medicine
May 12, 2011 02:19PM Barclays on Global Pharmaceuticals: Global Therapeutic Conference Preview: Multiple Sclerosis
May 9, 2011 11:02AM Notable Analyst Rating Changes 05/09: (BHI) (ETFC) (PEP) Upgraded; (SPLS) (MJN) (DRWI) Downgraded
Apr 21, 2011 02:21PM Notable 52-Week Highs and Lows of the Day 04/21: (SIRI) (UNH) (BIIB) High; (TEVA) (ZSTN) (AMR) Low
Apr 19, 2011 10:44AM Notable Analyst Rating Changes 04/19: (ZION) (NAV) (RBN) Upgraded; (GS) (ABAT) (CRU) Downgraded
Apr 12, 2011 02:21PM Barclays Maintains an 'Overweight' on Teva Pharma (TEVA); Detailed Laquinimod Results Support Our Positive View
Mar 25, 2011 01:29PM Barclays Maintains an 'Overweight' on Teva Pharma (TEVA); P&G Partnership Has Multiple Benefits
Mar 21, 2011 01:28PM Barclays on U.S. Specialty Pharmaceuticals: Mylan Influencing Lipitor Landscape?
Mar 18, 2011 02:37PM Barclays Maintains an 'Overweight' on Teva Pharma (TEVA); Takeaways from HC Conference Events
Feb 7, 2011 02:52PM Barclays Maintains an 'Overweight' on Teva Pharma (TEVA); First-Time FY11 Guidance Tomorrow a Key Focus
Jan 24, 2011 07:17AM Teva Pharma (TEVA) Enters $1.5B Revolving Credit Facility
Oct 26, 2010 03:43PM Barclays Reiterates an 'Overweight' on Teva Pharmaceutical (TEVA); Stock Lull Creates Opportunity
Jul 26, 2010 10:40AM Notable Analyst Rating Changes 07/26: AONE, PTEN, WFR, BX Upgraded; SAFM, TEVA, SLB, STM Downgraded
Jul 16, 2010 12:58PM Barclays on Specialty Pharmaceuticals: June Qtr Preview for Selected Companies
Jun 24, 2010 10:44AM Notable Analyst Rating Changes 06/24: PNW, HRP, BBBY, WYNN Upgraded; LOW, WTNY, HD, TRW Downgraded
Dec 7, 2009 11:07AM Notable Analyst Rating Changes 12/07: POT, BRCD, SPWRA, STP, JASO, AXP Upgraded; MMC, ABX, ALTH, AVP, ZLC Downgraded
Mar 13, 2009 10:16AM David Moenning's Daily State of the Markets: 3/13
Jan 2, 2009 02:21PM Top 15 For 2008 (No. 14): M&A Wreckage
Jun 16, 2008 09:29AM Pre-Open Movers 6/16: XM/Sirius (XMSR, SIRI) Up on Expected FCC Merger Approval; ACADIA (ACAD) Sinks As Drug Fails